SOURCE: Quantum Bit Induction Technology, Inc.

January 27, 2011 07:00 ET

Quantum Bit Induction Technology Inc. Introduces Applications of Quantum Control With Plans to Enter $150 Billion Biomedical Equipment Field

HOUSTON, TX--(Marketwire - January 27, 2011) - Quantum Bit Technology, Inc. (PINKSHEETS: QBII) continues general development plans involving applications of quantum control. In layman's terms, quantum control (coherent control) is a process that uses electromagnetic resonance to steer the randomness and control the statistical behavior of systems. Current applications of this advanced technology can be seen across many industries. It is already possible to control many processes, such as the direction of motion of electrons in semiconductors, breaking or forming chemical bonds, and stimulating biological processes.

The Company is applying the same principles to practical macro systems. Essentially any system with random components can be controlled to some extent with coherent control techniques. The Company is planning to implement quantum control in magnetic resonance imaging (MRI) creating a powerful therapeutic tool from the currently diagnostic MRI. Currently, the biomedical technology fields are valued at over $150 Billion and successfully manipulating electromagnetic pulses for imaging and therapeutic applications could help to heal patients with problems in deep tissue and/or internal organs.

Some other applications include, but are not limited to, enhancement of laser cutting tools, development of flexible circuits in order to support more dense, complex circuitry , and, perhaps most exciting, the development of varied biomedical applications.

References: www.quantumbit.com

www.pnas.org/content/101/49/16996.full#sec-3

Baumert, Thomas, Fielding, Helen, and Shapiro, Moshe. "Coherent Control" Journal of Physics B: Atomic, Molecular And Optical Physics Editorial. 41 (2008): 1-2.

Quantum Bit Induction Technology, Inc. is a Houston-based technology developer of Fusion, Wireless Power Transmission and Negative Group Delay, specifically how to render those technologies commercially viable. The Company's common stock is traded OTC under the symbol "QBII." More information is available through the company's website. Every stockholder or interested investor is encouraged to join our Shareholder's Group hosted by Yahoo! Groups. Important topics regarding this company are discussed through the Shareholder's Group. We encourage anyone interested in our work, company, history, or story to contact us. We welcome informed people as stockholders to share our future.

This release may include projections of future results and "forward-looking statements" as that term is defined in Section 27A of the Securities Act of 1933 as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 as amended (the "Exchange Act"). All statements that are included in this release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in these forward-looking statements are reasonable; it can give no assurances that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the expectations disclosed in this release, including, without limitation, in conjunction with those forward-looking statements contained in this release.

Contact Information